Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
John Curry; Susan Silva; Paul Rohde; Golda Ginsburg; Christopher Kratochvil; Anne Simons; Jerry Kirchner; Diane May; Betsy Kennard; Taryn Mayes; et al. (Profiled Author: Mark A Reinecke)
Archives of General Psychiatry. 2011;68(3):263-270.Abstract
Context: Major depressive disorder in adolescents is common and impairing. Efficacious treatments have been developed, but little is known about longer-term outcomes, including recurrence. Objectives: To determine whether adolescents who responded to short-term treatments or who received the most efficacious short-term treatment would have lower recurrence rates, and to identify predictors of recovery and recurrence. Design: Naturalistic follow-up study. Setting: Twelve academic sites in the United States. Participants: One hundred ninety-six adolescents (86 males and 110 females) randomized to 1 of 4 short-term interventions (fluoxetine hydrochloride treatment, cognitive behavioral therapy, their combination, or placebo) in the Treatment for Adolescents With Depression Study were followed up for 5 years after study entry (44.6% of the original Treatment for Adolescents With Depression Study sample). Main Outcome Measures: Recovery was defined as absence of clinically significant major depressive disorder symptoms on the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version interview for at least 8 weeks, and recurrence was defined as a new episode of major depressive disorder following recovery. Results: Almost all participants (96.4%) recovered from their index episode of major depressive disorder during the follow-up period. Recovery by 2 years was significantly more likely for short-term treatment responders (96.2%) than for partial responders or nonresponders (79.1%) (P<.001) but was not associated with having received the most efficacious short-term treatment (the combination of fluoxetine and cognitive behavioral therapy). Of the 189 participants who recovered, 88 (46.6%) had a recurrence. Recurrence was not predicted by full short-term treatment response or by original treatment. However, full or partial responders were less likely to have a recurrence (42.9%) than were non-responders (67.6%) (P=.03). Sex predicted recurrence (57.0% among females vs 32.9% among males; P=.02). Conclusions: Almost all depressed adolescents recovered. However, recurrence occurs in almost half of recovered adolescents, with higher probability in females in this age range. Further research should identify and address the vulnerabilities to recurrence that are more common among young women. ©2011 American Medical Association. All rights reserved.
PMID: 21041606 PMCID: PMC3074362
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Paul Rohde; Susan G. Silva; Simon T. Tonev; Betsy D. Kennard; Benedetto Vitiello; Christopher J. Kratochvil; Mark A. Reinecke; John F. Curry; Anne D. Simons; et al.Archives of General Psychiatry. 2008;65(4):447-455.
Marisa Elena Domino; E. Michael Foster; Benedetto Vitiello; Christopher J. Kratochvil; Barbara J. Burns; Susan G. Silva; Mark A. Reinecke; John S. MarchJournal of the American Academy of Child and Adolescent Psychiatry. 2009;48(7):711-720.
Emily G. Becker-Weidman; Mark A. Reinecke; Rachel H. Jacobs; Zoran Martinovich; Susan G. Silva; John S. MarchBehavioural and Cognitive Psychotherapy. 2009;37(3):267-291.
Appears in this Document